China Pharma Holdings, Inc.


$0.081 USD

$0.01 (10.96%)

Average Volume
Market Capitalization
P/E Ratio
Dividend Yield
Price Target
Year High
Year Low
Payout Ratio
Current Ratio

Industry, Sector & symbol

Stock Exchange American Stock Exchange
CEO Ms. Zhilin Li
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Current Symbol CPHI
CUSIP 16941T104
CIK 0001106644
Phone 86 89 8668 11730
Currency USD
Employees 234
Country CN


Debt-to-Equity Ratio 0.88
Payout Ratio 0.00
Current Ratio 0.82
Quick Ratio 0.25
Cash Ratio 0.19

Sales & Book Value

Annual Sales $8.1M
Price / Sales 0.59
Cash Flow 4234.44
Price / Cash Flow 0.00
Price / Book 0.18

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Neutral
Rating Score(0-5) 3
Research Coverage 0 Analysts


EPS (Most Recent Fiscal Year) $-1.94
Trailing P/E Ratio -0.23
PEG Ratio 0.00
P/E Growth 0.00
Net Income $-10.22M
Net Margin -60.54%
Pretax Margin -39.97%
Return on Equity -97.03%
Return on Assets -30.69%

Financials Score

AltmanZ Score -3.21
Piotroski Score 3.00
Working Capital -1.25M
Total Assets 15.35M
Ebit -2.07M
Market Cap 4.62M
Total Liabilities 9.24M

Poll Results

About China Pharma Holdings, Inc. (AMEX:CPHI) Stock

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide inj ... ection to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. was founded in 1993 and is based in Haikou, the People's Republic of China.

China Pharma (CPHI) Stock: Why It Has Been Volatile This Week

2022-12-06 13:02:19

The stock price of China Pharma (CPHI) has been volatile this week. This is why.

3 Penny Stocks, Are They Worth Buying Right Now?

2022-06-09 16:15:47

Check these three penny stocks out for your watchlist right now The post 3 Penny Stocks, Are They Worth Buying Right Now? appeared first on Penny Stocks to Buy, Picks, News and Information |

7 Discord Stocks Investors Are Pumping Higher

2021-08-23 13:09:35

Move over Reddit! These popular Discord stocks just might give fans of speculative opportunities the swing trades they're looking for.

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

2021-08-13 16:30:00

HAIKOU, China, Aug. 13, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI)  ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended June 30, 2021. Revenue decreased by 35.9% to $2.4 million for the three months ended June 30, 2021, as compared to $3.8 million for the three months ended June 30, 2020.

China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

2021-08-05 09:00:00

HAIKOU, China , Aug. 5, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its Candesartan hypertension product passed key bioequivalence tests. The Company plans to use the results of the key benchmark tests of consistency evaluation to apply for the National Medical Products Administration's (NMPA) approval.

Frequently Asked Questions

What is the current China Pharma Holdings, Inc. (CPHI) stock price?

China Pharma Holdings, Inc.(AMEX:CPHI) stock price is $0.081 in the last trading session. During the trading session, CPHI stock reached the peak price of $0.8 while $0.07 was the lowest point it dropped to. The percentage change in CPHI stock occurred in the recent session was 10.96% while the dollar amount for the price change in CPHI stock was $0.01.

CPHI's industry and sector of operation?

The AMEX listed CPHI is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of CPHI?

Ms. Zhilin Li | President, Chief Executive Officer, Chairman & Interim Chief Financial Officer
Ms. Huang Na C.F.A. | BOD Secretary & IR Manager

How many employees does CPHI have?

Number of CPHI employees currently stands at 234. CPHI operates from No. 17, Jinpan Road, Haikou, None 570216, CN.

Link for CPHI official website?

Official Website of CPHI is:

How do I contact CPHI?

CPHI could be contacted at phone #86 89 8668 11730 and can also be accessed through its website. CPHI operates from No. 17, Jinpan Road, Haikou, None 570216, CN.

How many shares of CPHI are traded daily?

The average number of CPHI shares traded daily for last 3 months was 1.85M.

What is the market cap of CPHI currently?

The market value of CPHI currently stands at $4.62M with its latest stock price at $0.081